Table 4.

Schedule of individual assessments

Evaluation	Screening Visit 00	Enrollment Visit 01 Year 1	Parental contact Visit 01Pd Year 2	Visit 02a Year 2	Time Use Surveyb	Parental contact Visit 02Pd Year 3	Visit 03a Year 3	Time Use Surveyb	Parental contact Visit 03Pd Year 4	Final visit Visit 04a Year 4
Study timepoint	−60 to 0 prior to visit 01	Sep–Dec 2020	−60 to 0 day(s) prior to visit 02	Jun–Nov 2021	Feb–Jun 2022	−60 to 0 day(s) prior to visit 03	Jun–Nov 2022	Feb–Jun 2023	−60 to 0 day(s) prior to visit 04	Jun–Nov 2023
Signed consent formc	X
Minor assent form	X
Eligibility review	X		X			X			X
Demographic surveyc	X
Collection of relevant medical conditionsc	X
Assessment of eligibility	X	X
Phlebotomy		X		X			X			X
Parental contactd				X			X			X
Knowledge of treatment arm surveyc, e				X			X			X
Time Use Survey					X			X

^aVisit will occur after the peak transmission season (Feb–June)

^bVisit will only be completed by a subset of participants enrolled in the Time Use Survey Sub-Study

^cTo be completed by the participant’s parent/legal guardian −60 to 0 days prior to the blood draw

^dIncludes confirmation of continuing study participation and collection of any significant health updates that would make the participant ineligible for study activities

^eTo be completed during parental contact